Form D · Biotechnology
RECODE THERAPEUTICS, INC.
Menlo Park, CA · CIK 0001693764
Offering snapshot reported Oct 23, 2025 · SEC filing
- Reported sold
- $29.4M Offering amount: $29.4M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 23, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2025 | Initial | $29,441,931 | No comparison | 26 | SEC filing |
| Sep 28, 2023 | Amendment | $259,799,396 | $49,799,374vs Jan 27, 2023 | 28 | SEC filing |
| Jan 27, 2023 | Amendment | $210,000,022 | $169,999,980vs Oct 25, 2021 | 24 | SEC filing |
| Jul 6, 2022 | Amendment | $160,000,009 | $119,999,967vs Oct 25, 2021 | 23 | SEC filing |
| Oct 25, 2021 | Initial | $40,000,042 | No comparison | 20 | SEC filing |
| Mar 20, 2020 | Initial | $27,499,993 | No comparison | 9 | SEC filing |
| Feb 8, 2019 | Amendment | $2,000,000 | $1,000,000vs Mar 2, 2017 | 1 | SEC filing |
| Mar 2, 2017 | Amendment | $1,000,000 | $500,000vs Jan 5, 2017 | 1 | SEC filing |
| Jan 5, 2017 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-561915
Source: Form D, filed Oct 23, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rana Al Hallaq | Director |
| Alan Colowick | Director |
| Rakhshita Dhar | Director |
| Julia Eastland | Executive |
| Kouki Harasaki | Director |
| Edward Hurwitz | Director |
| Arthur E Johnson | Director, Executive |
| Helen S. Kim | Director |
| David Lockhart | Executive |
| Trisha Millican | Director |
| Patricia Millican | Director |
| Dean Mitchell | Director |
| Oleg Nodelman | Director |
| Inai Park | Director |
| Ra Session Ii | Director |
| Shehnaaz Suliman | Director, Executive |
| Peter A. Thompson | Director |
| Michael Torres | Director |
| Basheer Zada | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1140 O'brien Drive
Menlo Park, CA, 94025
Menlo Park, CA, 94025